AI assistant
Sending…
AbbVie Inc. — Director's Dealing 2024
Dec 18, 2024
29755_dirs_2024-12-18_974bbf9e-23f1-42ea-bec5-bb72081cd3e0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2024-12-16
Reporting Person: Buckbee Kevin K (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-12-16 | Common Stock, $0.01 par value | M | 1800 | $93.50 | Acquired | 8783 | Direct |
| 2024-12-16 | Common Stock, $0.01 par value | S | 1800 | $172.24 | Disposed | 6983 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-12-16 | Option (Right to buy) | $93.50 | M | 1800 | Disposed | 2030-02-19 | Common Stock (1800) | Direct |
Footnotes
F1: Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.
More from AbbVie Inc.
Regulatory Filings
2026
May 12
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 29
Regulatory Filings
2026
Apr 3
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 23
Proxy Solicitation & Information Statement
2026
Mar 23
Regulatory Filings
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4